Dramatic changes in use of glucose-lowering drugs in Denmark from 2005 through 2021: a nationwide study

被引：0
|
作者：
Vilsboll, T. [1 ]
Andersen, J. H. [2 ]
Sondergaard, J. [3 ]
Thomsen, R. W. [4 ]
Pottegaard, A. [2 ]
机构：
[1] Univ Copenhagen, Steno Diabet Ctr Copenhagen, Clin Res, Copenhagen, Denmark
[2] Univ Southern Denmark, Clin Pharmacol Pharm & Environm Med, Odense, Denmark
[3] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense, Denmark
[4] Aarhus Univ Hosp, Dept Clin Epidemiol, Dept Clin Med, Aarhus, Denmark
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
579
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [1] Changes in the use of glucose-lowering drugs: A Danish nationwide study
    Pottegard, Anton
    Andersen, Jacob H.
    Sondergaard, Jens
    Thomsen, Reimar W.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1002 - 1010
  • [2] Changes in use of glucose-lowering drugs and physician responsibility: A Danish nationwide study
    Pottegard, Anton
    Thomsen, Reimar
    Andersen, Jacob Harbo
    Sondergaard, Jens
    Vilsboll, Tina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 183 - 184
  • [3] Nationwide Trends in Glucose-Lowering Drug Use in Denmark, 1999-2014
    Christensen, Diana H.
    Rungby, Jorgen
    Thomsen, Reimar W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 638 - 639
  • [4] Nationwide trends in glucose-lowering drug use, Denmark, 1999-2014
    Christensen, Diana Hedevang
    Rungby, Jorgen
    Thomsen, Reimar Wernich
    CLINICAL EPIDEMIOLOGY, 2016, 8 : 381 - 387
  • [5] Age discrepencies in the use of glucose-lowering medications: a nationwide cohort study
    Johansson, K.
    Petersen, T.
    Christensen, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S95 - S96
  • [6] Use of oral glucose-lowering drugs in a healthcare area
    Garcia de Paredes Esteban, Juan Carlos
    Mora Herrera, Cristina
    REVISTA ESPANOLA DE SALUD PUBLICA, 2021, 95
  • [7] Use of glucose-lowering drugs in Hungary between 2008 and 2017: the increasing use of novel glucose-lowering drug groups
    Csatordai, M.
    Benko, R.
    Matuz, M.
    Bor, A.
    Lengyel, C.
    Doro, P.
    DIABETIC MEDICINE, 2019, 36 (12) : 1612 - 1620
  • [8] Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents: a nationwide case-control study in Denmark
    Thomsen, R. W.
    Christensen, D. H.
    Kahlert, J.
    Knudsen, S. T.
    Pedersen, L.
    Norrelund, H.
    Dekkers, O. M.
    Douglas, I.
    Marchesini, G.
    Smeeth, L.
    Moller, N.
    Beck-Nielsen, H.
    Jorgensen, J. O.
    Sorensen, H. T.
    DIABETOLOGIA, 2015, 58 : S8 - S9
  • [9] No increase in new users of blood glucose-lowering drugs in Norway 2006–2011: a nationwide prescription database study
    Hanne Strøm
    Randi Selmer
    Kåre I Birkeland
    Henrik Schirmer
    Tore Julsrud Berg
    Anne Karen Jenum
    Kristian Midthjell
    Christian Berg
    Lars Christian Stene
    BMC Public Health, 14
  • [10] Risk of Pancreatic Cancer Associated With Use of Incretin-Based Therapy and other Glucose-Lowering Agents: A Nationwide Case-Control Study in Denmark
    Kahlert, Johnny
    Christensen, Diana H.
    Thomsen, Reimar W.
    Knudsen, Soren T.
    Pedersen, Lars
    Norrelund, Helene
    Dekkers, Olaf M.
    Douglas, Ian
    Marchesini, Giulio
    Smeeth, Liam
    Moller, Niels
    Beck-Nielsen, Henning
    Jorgensen, Jens Otto L.
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 429 - 430
12345